Four principal molecular subtypes of invasive breast cancer are characterized according to the expression of the estrogen receptor (ER) and progesterone receptor (PR), and the overexpression of the human epidermal growth factor receptor 2 (HER2). The gene discussed is ERBB2; the disease is invasive breast carcinoma.